Ann: Cyclopharm Bell Potter Healthcare Conference Presentation, page-4

  1. 26 Posts.
    lightbulb Created with Sketch. 5
    @tonyjones22 we meet again, except in my territory!

    G'day mate,

    It'll be interesting to see if Bell Potter has any conflict of interest that they are breaching covering both 4DX and CYC. I wonder what horse they back in this 2 horse race.

    @zereal "Targeting 2,000 of the 8,000 US nuclear medicinedepartments. 300 sites by the end of 2025." has me holding my breath as a SH, big asks and would certainly be baked into the DCF/SP targets, if they can hit it, this will be massive and can also leverage 8000 existing nuclear departments in the US. Assuming that 1 site = 1 department, 300/8000 for a valuable product is 3.75% penetration (actually a fair whack). Let's strap in and avoid the strap on.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.02
Change
-0.020(1.92%)
Mkt cap ! $113.3M
Open High Low Value Volume
$1.04 $1.05 $1.02 $220.9K 213.0K

Buyers (Bids)

No. Vol. Price($)
1 9803 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 49222 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.